Ptc Therapeutics (PTCT) Prepaid Assets (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly Prepaid Assets of $66.1 million in Q1 2026, down 1.86% quarter-over-quarter from $67.3 million in Q4 2025, and up 15.77% on a YoY basis from $57.1 million in Q1 2025.
Ptc Therapeutics (PTCT) Prepaid Assets (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Prepaid Assets history runs 15 years deep, the most recent figure standing at $66.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 15.77% year-over-year to $66.1 million; the TTM figure through Mar 2026 stood at $66.1 million (up 15.77% YoY), while the FY2025 annual figure was $67.3 million, up 52.67% from the prior year.
- Prepaid Assets was $66.1 million for Q1 2026 at Ptc Therapeutics, down from $67.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $150.5 million in Q4 2023 to a low of $29.6 million in Q1 2022.
- Historically, Prepaid Assets has averaged $63.8 million across 5 years, with a median of $56.2 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Prepaid Assets jumped 232.49% in 2023, then plunged 70.7% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $105.7 million in 2022, then jumped by 42.43% to $150.5 million in 2023, then slumped by 70.7% to $44.1 million in 2024, then soared by 52.67% to $67.3 million in 2025, then declined by 1.86% to $66.1 million in 2026.
- The last three Prepaid Assets figures came in at $66.1 million (Q1 2026), $67.3 million (Q4 2025), and $64.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.05 Mn |
| Dec 31, 2025 | 67.31 Mn |
| Sep 30, 2025 | 64.22 Mn |
| Jun 30, 2025 | 53.53 Mn |
| Mar 31, 2025 | 57.06 Mn |
| Dec 31, 2024 | 44.09 Mn |
| Sep 30, 2024 | 32.55 Mn |
| Jun 30, 2024 | 45.64 Mn |
| Mar 31, 2024 | 56.21 Mn |
| Dec 31, 2023 | 150.49 Mn |
| Sep 30, 2023 | 44.08 Mn |
| Jun 30, 2023 | 42.23 Mn |
| Mar 31, 2023 | 98.57 Mn |
| Dec 31, 2022 | 105.66 Mn |
| Sep 30, 2022 | 89.56 Mn |
| Jun 30, 2022 | 38.18 Mn |
| Mar 31, 2022 | 29.65 Mn |
| Dec 31, 2021 | 54.68 Mn |
| Sep 30, 2021 | 30.94 Mn |
| Jun 30, 2021 | 23.91 Mn |